Get the Stockscreener App
8.93
3.72%
0.32
After Hours:
8.88
-0.05
-0.56%
Delcath Systems Inc stock is traded at $8.93, with a volume of 686.40K.
It is up +3.72% in the last 24 hours and down -21.46% over the past month.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
See More
Previous Close:
$8.61
Open:
$8.44
24h Volume:
686.40K
Relative Volume:
0.84
Market Cap:
$312.38M
Revenue:
$2.07M
Net Income/Loss:
$-47.68M
P/E Ratio:
-3.1667
EPS:
-2.82
Net Cash Flow:
$-31.31M
1W Performance:
+3.36%
1M Performance:
-21.46%
6M Performance:
-42.28%
1Y Performance:
-3.25%
1-Day Range:
$8.43
$9.19
1-Week Range:
$8.33
$9.19
52-Week Range:
$8.33
$18.23
Delcath Systems Inc Stock (DCTH) Company Profile
Name
Delcath Systems Inc
Sector
Industry
Phone
(518) 743-8892
Address
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Compare DCTH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
8.93 | 304.05M | 2.07M | -47.68M | -31.31M | -2.82 |
|
ABT
Abbott Laboratories
|
130.59 | 224.77B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
102.69 | 155.63B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
362.22 | 142.80B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
95.87 | 123.31B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
86.30 | 49.97B | 5.88B | 1.34B | 799.60M | 2.3489 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-28-24 | Initiated | Craig Hallum | Buy |
| May-14-24 | Initiated | Stephens | Overweight |
| Jul-26-22 | Resumed | Canaccord Genuity | Buy |
| Dec-10-21 | Initiated | H.C. Wainwright | Buy |
| Mar-09-21 | Initiated | Canaccord Genuity | Buy |
| Jan-05-21 | Initiated | BTIG Research | Buy |
| Jun-01-20 | Initiated | Laidlaw | Buy |
View All
Delcath Systems Inc Stock (DCTH) Latest News
Delcath Systems announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Delcath Systems (NASDAQ: DCTH) grants 62,500 inducement options at $9.83 for new hires - Stock Titan
Delcath Systems (NASDAQ:DCTH) CEO Gerard Michel Acquires 11,500 Shares of Stock - MarketBeat
Delcath Systems Announces Publication of Real-World Evidence Supporting Early Use of Liver-Directed Therapy with PHP in Achieving Long-Term Survival for Metastatic Uveal Melanoma Patients - BioSpace
Los Angeles Capital Management LLC Purchases New Holdings in Delcath Systems, Inc. $DCTH - MarketBeat
Delcath Systems Inc DV3R Stock Analysis and ForecastQuarterly Earnings Review & Trade Like a Pro Using AI Edge - earlytimes.in
Can Delcath Systems Inc. (DV3R) stock beat analyst consensusWeekly Trade Report & Low Drawdown Momentum Ideas - newser.com
Why Delcath Systems Inc. (DV3R) stock trades below fair value2025 Investor Takeaways & Verified Momentum Stock Alerts - newser.com
Study suggests early liver-directed therapies improve survival in melanoma By Investing.com - Investing.com Nigeria
How Delcath Systems Inc. (DV3R) stock reacts to Fed tighteningWeekly Trade Recap & Verified Momentum Watchlists - newser.com
Real time breakdown of Delcath Systems Inc. stock performanceJuly 2025 Breakouts & Weekly High Potential Stock Alerts - newser.com
Insider Buying: Gerard Michel Acquires Shares of Delcath Systems Inc (DCTH) - GuruFocus
Will Delcath Systems Inc. benefit from macro trendsJuly 2025 Trade Ideas & Safe Capital Growth Plans - newser.com
Delcath Systems CEO Michel buys $98k in shares - Investing.com India
Delcath Systems Shares Tick Higher After Study Highlights Strong Outcomes for Liver Cancer Treatment - MSN
Delcath Systems (DCTH) Study Highlights Promising Liver Therapy for Cancer Patients - GuruFocus
Delcath Systems stock rises after positive study results on liver cancer treatment - Investing.com
Delcath (NASDAQ: DCTH) reports 37.35 mo OS, 10.28 mo PFS using PHP in uveal melanoma - Stock Titan
Delcath Systems (DCTH): Evaluating Valuation After Third Quarter Profitability Turnaround - Yahoo Finance
Is Delcath Systems Inc. showing signs of accumulationMarket Risk Analysis & Stock Portfolio Risk Management - newser.com
Order flow analysis tools used on Delcath Systems Inc.Earnings Recap Summary & AI Driven Stock Movement Reports - newser.com
Understanding the Setup: (DCTH) and Scalable Risk - news.stocktradersdaily.com
Can volume confirm reversal in Delcath Systems Inc.July 2025 Retail & Fast Entry High Yield Tips - newser.com
Delcath Systems’ Earnings Call: Mixed Sentiments and Future Plans - MSN
Delcath Systems FY2025 EPS Forecast Lowered by HC Wainwright - MarketBeat
Delcath outlines 40 active center target and 150% HEPZATO treatment volume growth for 2025 amid CHOPIN data momentum - MSN
Delcath Systems Q1 EPS Forecast Boosted by HC Wainwright - MarketBeat
Volatility clustering patterns for Delcath Systems Inc.2025 Dividend Review & Risk Controlled Daily Trade Plans - newser.com
What insider purchases suggest about Delcath Systems Inc. (DV3R) stockCPI Data & AI Powered Buy and Sell Recommendations - newser.com
Delcath Systems to Participate in Upcoming November 2025 Investor Conferences - BioSpace
Delcath Systems, Inc. (NASDAQ:DCTH) Q3 2025 Earnings Call Transcript - Insider Monkey
Delcath Systems to Participate in Upcoming Investor Conferences - Yahoo Finance
Delcath: Temporary Headwinds Are No Cause For Concern (NASDAQ:DCTH) - Seeking Alpha
Delcath Systems Reports Strong Q3 2025 Growth - MSN
Stephens Has Lowered Expectations for Delcath Systems (NASDAQ:DCTH) Stock Price - MarketBeat
Delcath Systems (DCTH) Profitability and Margin Gains Reinforce Value Bull Case, Despite Dilution Concerns - Yahoo Finance
Delcath Systems Inc Stock (DCTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Delcath Systems Inc Stock (DCTH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Vukovic Vojo | CHIEF MEDICAL OFFICER |
Jun 12 '25 |
Option Exercise |
4.78 |
42,000 |
200,760 |
168,882 |
2.78%
0.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):